TMIC-42. DEVELOPMENT OF NOVEL SPRAY-TYPE FLUORESCENT PROBES FOR BRAIN TUMORS

Abstract PURPOSE: 5-Amino Levulinic Acid (5-ALA) is commonly used as an intraoperative aid in malignant glioma surgery, which has been proved to be effective for more radical tumor resection and better patient prognosis. However, there are some limitations in its use, such as false positivity, false...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-oncology (Charlottesville, Va.) Va.), 2018-11, Vol.20 (suppl_6), p.vi265-vi265
Hauptverfasser: Kitagawa, Yosuke, Tanaka, Shota, Ogasawara, Akira, Kuriki, Yugo, Yamamoto, Kyoko, Koike, Tsukasa, Hana, Taijyun, Takahashi, Satoshi, Nejo, Takahide, Nomura, Masashi, Takayanagi, Shunsaku, Kamiya, Mako, Urano, Yasuteru, Saito, Nobuhito
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page vi265
container_issue suppl_6
container_start_page vi265
container_title Neuro-oncology (Charlottesville, Va.)
container_volume 20
creator Kitagawa, Yosuke
Tanaka, Shota
Ogasawara, Akira
Kuriki, Yugo
Yamamoto, Kyoko
Koike, Tsukasa
Hana, Taijyun
Takahashi, Satoshi
Nejo, Takahide
Nomura, Masashi
Takayanagi, Shunsaku
Kamiya, Mako
Urano, Yasuteru
Saito, Nobuhito
description Abstract PURPOSE: 5-Amino Levulinic Acid (5-ALA) is commonly used as an intraoperative aid in malignant glioma surgery, which has been proved to be effective for more radical tumor resection and better patient prognosis. However, there are some limitations in its use, such as false positivity, false negativity, and inability of re-administration. We aim to develop a novel fluorescent labeling system, which can be repeatedly administered by spray during surgery, using hydroxymethyl rhodamine green (HMRG) and 2 methyl siliconrhodamine (2MeSiR600) as host fluorescent nuclei originally designed at our university for cancer detection, complementing 5-ALA. METHODS Four groups of homogenized samples were prepared from frozen tissues which consisted of 10 peritumoral specimens, 5 glioblastomas, 5 astrocytomas, and 5 oligodendrogliomas. Probe screening was performed using the fluorescent probe library comprised of HMRG and 2MeSiR600 host fluorescent nuclei combined with various types of dipeptides. More than 720 kinds of fluorescent probes were applied to homogenized lysates. According to the fluorescence intensity measured over time after application, probes exhibiting strong focal fluorescent marks with large difference between peritumor and tumor tissues were selected as valid probes. The selected probes were then validated by the experiment using fresh specimens. RESULTS & DISCUSSION: The top probes were selected based upon the experiments using homogenized lysates as well as fresh specimens. They were validated prospectively with more surgical cases. With the combination of the two types of fluorescent host nuclei, glioblastoma can be identified in multi-color. CONCLUSION Fluorescent probes with HMRG and 2MeSiR 600 host nuclei can be effective for intraoperative detection of glioma.
doi_str_mv 10.1093/neuonc/noy148.1101
format Article
fullrecord <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6217074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/neuonc/noy148.1101</oup_id><sourcerecordid>10.1093/neuonc/noy148.1101</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1801-6b2b9ca2306e4ff9029df7755ebb9e9e1fb9f9f1a01a7cffb63d583d51d9a58a3</originalsourceid><addsrcrecordid>eNqNkEFPg0AQhTdGE2v1D3jiD2y7s7DAXkxaBG1CuwSoSU-bBXa1poUGrEn_vVSMiTcPk5mXN-8dPoTugUyAcHta62NTl9O6OYHjTwAIXKARMGpj5rvu5fdNsc_Au0Y3XfdOCAXmwgjF-XIRYIdOrMfwJYxFsgxXuSUiayV6aWVJOtvgfJOEVhSvRRpmwdlPUjEPMysSqTVPZ4uVla-XIs1u0ZVRu07f_ewxWkdhHjzjWDwtglmMS_AJYLegBS8VtYmrHWM4obwynseYLgquuQZTcMMNKALKK40pXLtifj9QccV8ZY_Rw9B7OBZ7XZW6_mjVTh7a7V61J9morfzr1Ns3-dp8SpeCRzynL6BDQdk2Xddq85sFIs9A5QBUDkDlGWgfwkOoOR7-8_8FoPZ2mQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>TMIC-42. DEVELOPMENT OF NOVEL SPRAY-TYPE FLUORESCENT PROBES FOR BRAIN TUMORS</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>PubMed Central</source><creator>Kitagawa, Yosuke ; Tanaka, Shota ; Ogasawara, Akira ; Kuriki, Yugo ; Yamamoto, Kyoko ; Koike, Tsukasa ; Hana, Taijyun ; Takahashi, Satoshi ; Nejo, Takahide ; Nomura, Masashi ; Takayanagi, Shunsaku ; Kamiya, Mako ; Urano, Yasuteru ; Saito, Nobuhito</creator><creatorcontrib>Kitagawa, Yosuke ; Tanaka, Shota ; Ogasawara, Akira ; Kuriki, Yugo ; Yamamoto, Kyoko ; Koike, Tsukasa ; Hana, Taijyun ; Takahashi, Satoshi ; Nejo, Takahide ; Nomura, Masashi ; Takayanagi, Shunsaku ; Kamiya, Mako ; Urano, Yasuteru ; Saito, Nobuhito</creatorcontrib><description>Abstract PURPOSE: 5-Amino Levulinic Acid (5-ALA) is commonly used as an intraoperative aid in malignant glioma surgery, which has been proved to be effective for more radical tumor resection and better patient prognosis. However, there are some limitations in its use, such as false positivity, false negativity, and inability of re-administration. We aim to develop a novel fluorescent labeling system, which can be repeatedly administered by spray during surgery, using hydroxymethyl rhodamine green (HMRG) and 2 methyl siliconrhodamine (2MeSiR600) as host fluorescent nuclei originally designed at our university for cancer detection, complementing 5-ALA. METHODS Four groups of homogenized samples were prepared from frozen tissues which consisted of 10 peritumoral specimens, 5 glioblastomas, 5 astrocytomas, and 5 oligodendrogliomas. Probe screening was performed using the fluorescent probe library comprised of HMRG and 2MeSiR600 host fluorescent nuclei combined with various types of dipeptides. More than 720 kinds of fluorescent probes were applied to homogenized lysates. According to the fluorescence intensity measured over time after application, probes exhibiting strong focal fluorescent marks with large difference between peritumor and tumor tissues were selected as valid probes. The selected probes were then validated by the experiment using fresh specimens. RESULTS &amp; DISCUSSION: The top probes were selected based upon the experiments using homogenized lysates as well as fresh specimens. They were validated prospectively with more surgical cases. With the combination of the two types of fluorescent host nuclei, glioblastoma can be identified in multi-color. CONCLUSION Fluorescent probes with HMRG and 2MeSiR 600 host nuclei can be effective for intraoperative detection of glioma.</description><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/noy148.1101</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Abstracts</subject><ispartof>Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi265-vi265</ispartof><rights>The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217074/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217074/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,725,778,782,883,1581,27911,27912,53778,53780</link.rule.ids></links><search><creatorcontrib>Kitagawa, Yosuke</creatorcontrib><creatorcontrib>Tanaka, Shota</creatorcontrib><creatorcontrib>Ogasawara, Akira</creatorcontrib><creatorcontrib>Kuriki, Yugo</creatorcontrib><creatorcontrib>Yamamoto, Kyoko</creatorcontrib><creatorcontrib>Koike, Tsukasa</creatorcontrib><creatorcontrib>Hana, Taijyun</creatorcontrib><creatorcontrib>Takahashi, Satoshi</creatorcontrib><creatorcontrib>Nejo, Takahide</creatorcontrib><creatorcontrib>Nomura, Masashi</creatorcontrib><creatorcontrib>Takayanagi, Shunsaku</creatorcontrib><creatorcontrib>Kamiya, Mako</creatorcontrib><creatorcontrib>Urano, Yasuteru</creatorcontrib><creatorcontrib>Saito, Nobuhito</creatorcontrib><title>TMIC-42. DEVELOPMENT OF NOVEL SPRAY-TYPE FLUORESCENT PROBES FOR BRAIN TUMORS</title><title>Neuro-oncology (Charlottesville, Va.)</title><description>Abstract PURPOSE: 5-Amino Levulinic Acid (5-ALA) is commonly used as an intraoperative aid in malignant glioma surgery, which has been proved to be effective for more radical tumor resection and better patient prognosis. However, there are some limitations in its use, such as false positivity, false negativity, and inability of re-administration. We aim to develop a novel fluorescent labeling system, which can be repeatedly administered by spray during surgery, using hydroxymethyl rhodamine green (HMRG) and 2 methyl siliconrhodamine (2MeSiR600) as host fluorescent nuclei originally designed at our university for cancer detection, complementing 5-ALA. METHODS Four groups of homogenized samples were prepared from frozen tissues which consisted of 10 peritumoral specimens, 5 glioblastomas, 5 astrocytomas, and 5 oligodendrogliomas. Probe screening was performed using the fluorescent probe library comprised of HMRG and 2MeSiR600 host fluorescent nuclei combined with various types of dipeptides. More than 720 kinds of fluorescent probes were applied to homogenized lysates. According to the fluorescence intensity measured over time after application, probes exhibiting strong focal fluorescent marks with large difference between peritumor and tumor tissues were selected as valid probes. The selected probes were then validated by the experiment using fresh specimens. RESULTS &amp; DISCUSSION: The top probes were selected based upon the experiments using homogenized lysates as well as fresh specimens. They were validated prospectively with more surgical cases. With the combination of the two types of fluorescent host nuclei, glioblastoma can be identified in multi-color. CONCLUSION Fluorescent probes with HMRG and 2MeSiR 600 host nuclei can be effective for intraoperative detection of glioma.</description><subject>Abstracts</subject><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqNkEFPg0AQhTdGE2v1D3jiD2y7s7DAXkxaBG1CuwSoSU-bBXa1poUGrEn_vVSMiTcPk5mXN-8dPoTugUyAcHta62NTl9O6OYHjTwAIXKARMGpj5rvu5fdNsc_Au0Y3XfdOCAXmwgjF-XIRYIdOrMfwJYxFsgxXuSUiayV6aWVJOtvgfJOEVhSvRRpmwdlPUjEPMysSqTVPZ4uVla-XIs1u0ZVRu07f_ewxWkdhHjzjWDwtglmMS_AJYLegBS8VtYmrHWM4obwynseYLgquuQZTcMMNKALKK40pXLtifj9QccV8ZY_Rw9B7OBZ7XZW6_mjVTh7a7V61J9morfzr1Ns3-dp8SpeCRzynL6BDQdk2Xddq85sFIs9A5QBUDkDlGWgfwkOoOR7-8_8FoPZ2mQ</recordid><startdate>20181105</startdate><enddate>20181105</enddate><creator>Kitagawa, Yosuke</creator><creator>Tanaka, Shota</creator><creator>Ogasawara, Akira</creator><creator>Kuriki, Yugo</creator><creator>Yamamoto, Kyoko</creator><creator>Koike, Tsukasa</creator><creator>Hana, Taijyun</creator><creator>Takahashi, Satoshi</creator><creator>Nejo, Takahide</creator><creator>Nomura, Masashi</creator><creator>Takayanagi, Shunsaku</creator><creator>Kamiya, Mako</creator><creator>Urano, Yasuteru</creator><creator>Saito, Nobuhito</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20181105</creationdate><title>TMIC-42. DEVELOPMENT OF NOVEL SPRAY-TYPE FLUORESCENT PROBES FOR BRAIN TUMORS</title><author>Kitagawa, Yosuke ; Tanaka, Shota ; Ogasawara, Akira ; Kuriki, Yugo ; Yamamoto, Kyoko ; Koike, Tsukasa ; Hana, Taijyun ; Takahashi, Satoshi ; Nejo, Takahide ; Nomura, Masashi ; Takayanagi, Shunsaku ; Kamiya, Mako ; Urano, Yasuteru ; Saito, Nobuhito</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1801-6b2b9ca2306e4ff9029df7755ebb9e9e1fb9f9f1a01a7cffb63d583d51d9a58a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abstracts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kitagawa, Yosuke</creatorcontrib><creatorcontrib>Tanaka, Shota</creatorcontrib><creatorcontrib>Ogasawara, Akira</creatorcontrib><creatorcontrib>Kuriki, Yugo</creatorcontrib><creatorcontrib>Yamamoto, Kyoko</creatorcontrib><creatorcontrib>Koike, Tsukasa</creatorcontrib><creatorcontrib>Hana, Taijyun</creatorcontrib><creatorcontrib>Takahashi, Satoshi</creatorcontrib><creatorcontrib>Nejo, Takahide</creatorcontrib><creatorcontrib>Nomura, Masashi</creatorcontrib><creatorcontrib>Takayanagi, Shunsaku</creatorcontrib><creatorcontrib>Kamiya, Mako</creatorcontrib><creatorcontrib>Urano, Yasuteru</creatorcontrib><creatorcontrib>Saito, Nobuhito</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kitagawa, Yosuke</au><au>Tanaka, Shota</au><au>Ogasawara, Akira</au><au>Kuriki, Yugo</au><au>Yamamoto, Kyoko</au><au>Koike, Tsukasa</au><au>Hana, Taijyun</au><au>Takahashi, Satoshi</au><au>Nejo, Takahide</au><au>Nomura, Masashi</au><au>Takayanagi, Shunsaku</au><au>Kamiya, Mako</au><au>Urano, Yasuteru</au><au>Saito, Nobuhito</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TMIC-42. DEVELOPMENT OF NOVEL SPRAY-TYPE FLUORESCENT PROBES FOR BRAIN TUMORS</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><date>2018-11-05</date><risdate>2018</risdate><volume>20</volume><issue>suppl_6</issue><spage>vi265</spage><epage>vi265</epage><pages>vi265-vi265</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><abstract>Abstract PURPOSE: 5-Amino Levulinic Acid (5-ALA) is commonly used as an intraoperative aid in malignant glioma surgery, which has been proved to be effective for more radical tumor resection and better patient prognosis. However, there are some limitations in its use, such as false positivity, false negativity, and inability of re-administration. We aim to develop a novel fluorescent labeling system, which can be repeatedly administered by spray during surgery, using hydroxymethyl rhodamine green (HMRG) and 2 methyl siliconrhodamine (2MeSiR600) as host fluorescent nuclei originally designed at our university for cancer detection, complementing 5-ALA. METHODS Four groups of homogenized samples were prepared from frozen tissues which consisted of 10 peritumoral specimens, 5 glioblastomas, 5 astrocytomas, and 5 oligodendrogliomas. Probe screening was performed using the fluorescent probe library comprised of HMRG and 2MeSiR600 host fluorescent nuclei combined with various types of dipeptides. More than 720 kinds of fluorescent probes were applied to homogenized lysates. According to the fluorescence intensity measured over time after application, probes exhibiting strong focal fluorescent marks with large difference between peritumor and tumor tissues were selected as valid probes. The selected probes were then validated by the experiment using fresh specimens. RESULTS &amp; DISCUSSION: The top probes were selected based upon the experiments using homogenized lysates as well as fresh specimens. They were validated prospectively with more surgical cases. With the combination of the two types of fluorescent host nuclei, glioblastoma can be identified in multi-color. CONCLUSION Fluorescent probes with HMRG and 2MeSiR 600 host nuclei can be effective for intraoperative detection of glioma.</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/neuonc/noy148.1101</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1522-8517
ispartof Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi265-vi265
issn 1522-8517
1523-5866
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6217074
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); PubMed Central
subjects Abstracts
title TMIC-42. DEVELOPMENT OF NOVEL SPRAY-TYPE FLUORESCENT PROBES FOR BRAIN TUMORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T10%3A34%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TMIC-42.%20DEVELOPMENT%20OF%20NOVEL%20SPRAY-TYPE%20FLUORESCENT%20PROBES%20FOR%20BRAIN%20TUMORS&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Kitagawa,%20Yosuke&rft.date=2018-11-05&rft.volume=20&rft.issue=suppl_6&rft.spage=vi265&rft.epage=vi265&rft.pages=vi265-vi265&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/noy148.1101&rft_dat=%3Coup_pubme%3E10.1093/neuonc/noy148.1101%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/neuonc/noy148.1101&rfr_iscdi=true